Reports and Briefs on Pharmaceuticals

The following industries match your search criteria:

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | » »|

Click here to sort results by relevance. Click on heading titles to sort results by different field.

Type Product title / description Pub Price
Report
Report

Zydus Cadila: Biosimilars Company Analysis

Analysis of Zydus Cadila’s corporate history, corporate relationships, biosimilars development pipeline, and Datamonitor's evaluation of the company's strategy and key strengths, weaknesses, opportunities and threats.

Published By Datamonitor
06 Jul 2012 $2800
Buy
Report
Report

US: Healthcare Reform, Intellectual Property and Regulatory Update

Datamonitor’s report provides an overview of developments regarding drug regulation, healthcare reform, and intellectual property issues in the US.

Published By Datamonitor
15 Nov 2011 $1520
Buy
Report
Report

US Pharmaceutical Market Overview - Healthcare reform, economic pressures and the patent cliff set to impact Pharma

Overview of the US pharmaceutical market including socioeconomic and demographic trends, regulatory issues, generics and biosimilars analysis and pharmaceutical company infrastructure analysis.

Published By Datamonitor
27 Sep 2010 $11400
Buy
Report
Report

Turkey: Pharmaceutical Industry Infrastructure Overview

This report provides an overview of research and development, manufacturing, outsourcing, and distribution trends, as well as infrastructure profiles for the leading pharmaceutical companies in Turkey.

Published By Datamonitor
29 Jun 2011 $1520
Buy
Report
Report

Turkey: Generics and Biosimilars Overview

Overview of the generics and biosimilars landscape including, regulatory issues, drivers and resistors to uptake, level of penetration, and key players operating in the market.

Published By Datamonitor
29 Jun 2011 $1520
Buy
Report
Report

Teva: Biosimilars Company Analysis

Analysis of Teva’s corporate history, corporate relationships, biosimilars development pipeline, and Datamonitor's evaluation of the company's strategy and key strengths, weaknesses, opportunities and threats.

Published By Datamonitor
06 Jul 2012 $2800
Buy
Report
Report

Teva Pharma. Industries Ltd: PharmaVitae Generics Report

Analysis of Teva's corporate strategy and sales performance in 2010 to 2016.

Published By Datamonitor
04 May 2012 $2800
Buy
Report
Report

Takeda Pharmaceutical Co., Ltd: PharmaVitae Report

Analysis of Takeda's corporate strategy, marketed portfolio, pipeline potential and financial position in 2010 and to 2016

Published By Datamonitor
14 Dec 2011 $2800
Buy
Report
Report

Strategies for Comparative Efficacy Trials

Comparative efficacy data are not necessarily required for approval but are increasingly demanded by payers. Meeting the expectations of all stakeholders can be challenging, making comparator selection and trial design complex decisions.

Published By Datamonitor
23 Aug 2012 $2800
Buy
Report
Report

Spain Pharmaceutical Market Overview – Continued stagnation as generics and price cuts erode market value

Overview of the pharmaceutical market in Spain including socioeconomic and demographic trends, regulatory issues, generics and biosimilars analysis, and pharmaceutical market and pharmaceutical company infrastructure analysis.

Published By Datamonitor
11 Oct 2012 $2800
Buy

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | » »|

No help is available.